Form D · Biotechnology
POLARITYTE, INC.
Salt Lake City, UT · CIK 0001076682
Offering snapshot reported Jun 14, 2022 · SEC filing
- Reported sold
- $4M Offering amount: $11.6M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Jun 5, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2022 | Initial | $3,998,417 | No comparison | 1 | SEC filing |
| Sep 26, 2017 | Initial | $17,750,002 | No comparison | 10 | SEC filing |
| Apr 10, 2017 | Initial | $1 | No comparison | 1 | SEC filing |
| Dec 21, 2016 | Initial | $2,278,001 | No comparison | 28 | SEC filing |
| Sep 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06c, 4a5
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $260K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-449189
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Jun 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Beeghley | Director |
| Mohit Bhansali | Director |
| Willie Bogan | Director |
| Michael Brauser | Director |
| Peter Cohen | Director |
| Jeff Dyer | Director |
| Jeffrey Dyer | Director |
| Steve Gorlin | Director |
| Richard Hague | Executive |
| Barry Honig | Director |
| Cameron Hoyler | Executive |
| Denver Lough | Promoter |
| Jon Mogford | Director |
| Michael Neumeister | Executive |
| Chris Nolet | Director |
| Jacob Patterson | Executive |
| David Seaburg | Director |
| John Stetson | Director, Executive |
| Edward Swanson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1960 S. 4250 West
Salt Lake City, UT, 84104
Salt Lake City, UT, 84104